Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 175 Total
SION - Sionna Therapeutics Inc - Stock Price Chart
TickerSION [NASD]
CompanySionna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap551.38MEPS (ttm)-
P/E-EPS this Y85.65%
Forward P/E-EPS next Y-8.28%
PEG-EPS past 5Y-
P/S-EPS next 5Y44.91%
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own38.70%Inst Own30.37%
Insider Trans25.51%Inst Trans28.05%
Short Float4.91%EarningsMar 20/b
Analyst Recom1.00Target Price38.50
Avg Volume269.93K52W Range13.20 - 25.19
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TPG GP A, LLC10% OwnerFeb 10 '25Buy18.001,125,00020,250,0006,684,962Feb 12 05:21 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 10 '25Buy18.001,125,00020,250,0006,923,365Feb 10 05:04 PM
ORBIMED ADVISORS LLCDirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:28 PM
Thompson Peter A.DirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:05 PM
Booth BruceDirectorFeb 10 '25Buy18.0060,0001,080,000807,727Feb 10 04:05 PM
QNTM - Quantum BioPharma Ltd - Stock Price Chart
TickerQNTM [NASD]
CompanyQuantum BioPharma Ltd
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap11.67MEPS (ttm)-14.87
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y31.10%
P/S-EPS next 5Y-
P/B0.70EPS Q/Q-122.28%
Dividend-Sales Q/Q-
Insider Own17.20%Inst Own3.64%
Insider Trans0.00%Inst Trans41.41%
Short Float3.09%EarningsNov 13
Analyst Recom1.00Target Price12.80
Avg Volume2.63M52W Range2.70 - 47.12
Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
CAMP - CAMP4 Therapeutics Corp - Stock Price Chart
TickerCAMP [NASD, RUT]
CompanyCAMP4 Therapeutics Corp
CountryUSA
IndustryBiotechnology
Market Cap90.93MEPS (ttm)-
P/E-EPS this Y54.05%
Forward P/E-EPS next Y18.67%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own86.88%Inst Own13.61%
Insider Trans58.88%Inst Trans13.94%
Short Float12.42%EarningsFeb 26
Analyst Recom1.00Target Price17.50
Avg Volume52.97K52W Range3.50 - 12.30
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Northpond Ventures II GP, LLC10% OwnerOct 15 '24Buy11.00763,6368,399,996763,636Oct 17 06:34 PM
AH Equity Partners Bio I, L.L.10% OwnerOct 15 '24Buy11.00727,2727,999,9921,579,885Oct 17 05:05 PM
Enavate Sciences GP, LLC10% OwnerOct 15 '24Buy11.001,363,63614,999,9963,785,802Oct 17 04:15 PM
Polaris Management Co. VII, L.10% OwnerOct 15 '24Buy11.00909,0909,999,990909,090Oct 15 06:00 PM
5AM Partners VI, LLC10% OwnerOct 15 '24Buy11.00909,0909,999,9902,625,145Oct 15 05:56 PM
ARMP - Armata Pharmaceuticals Inc - Stock Price Chart
TickerARMP [AMEX]
CompanyArmata Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap65.75MEPS (ttm)-1.64
P/E-EPS this Y-117.98%
Forward P/E-EPS next Y-
PEG-EPS past 5Y47.98%
P/S12.02EPS next 5Y-
P/B-EPS Q/Q82.46%
Dividend-Sales Q/Q142.69%
Insider Own70.28%Inst Own3.84%
Insider Trans0.00%Inst Trans0.36%
Short Float0.06%EarningsMar 20/a
Analyst Recom1.00Target Price7.00
Avg Volume10.61K52W Range1.80 - 4.25
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
FPAY - FlexShopper Inc - Stock Price Chart
TickerFPAY [NASD]
CompanyFlexShopper Inc
CountryUSA
IndustryRental & Leasing Services
Market Cap30.04MEPS (ttm)-0.16
P/E-EPS this Y81.05%
Forward P/E5.53EPS next Y362.07%
PEG-EPS past 5Y18.04%
P/S0.22EPS next 5Y-
P/B4.29EPS Q/Q991.67%
Dividend-Sales Q/Q22.95%
Insider Own61.77%Inst Own15.47%
Insider Trans0.38%Inst Trans-4.81%
Short Float1.70%EarningsNov 14/b
Analyst Recom1.00Target Price3.25
Avg Volume222.74K52W Range0.97 - 2.37
FlexShopper, Inc. is a financial technology company, which engages in the provision of electronics, home furnishings, and other durable goods to underserved consumers on a lease-to-own (LTO) basis through its patented e-commerce marketplace. The firm is also involved in providing LTO and loan technology platforms to a growing number of retailers and e-retailers to facilitate transactions with consumers without access to traditional financing. The company was founded by George F. Rubin, Morry F. Rubin, and Brad Mitchell Bernstein on August 16, 2006 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heiser Harold Russell Jr.CEODec 23 '24Buy1.4530,00043,500969,874Dec 30 04:01 PM
Dvorkin HowardDirectorDec 26 '24Buy1.5410,00015,4004,551,558Dec 30 04:01 PM
Dvorkin HowardDirectorDec 27 '24Buy1.4610,00014,6004,561,458Dec 30 04:01 PM
Dvorkin HowardDirectorAug 22 '24Buy1.1716,20018,9544,534,558Aug 26 05:29 PM
Dvorkin HowardDirectorAug 23 '24Buy1.106,9007,5904,541,458Aug 26 05:29 PM
ORIC - ORIC Pharmaceuticals Inc - Stock Price Chart
TickerORIC [NASD, RUT]
CompanyORIC Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap483.02MEPS (ttm)-1.83
P/E-EPS this Y-11.47%
Forward P/E-EPS next Y4.42%
PEG-EPS past 5Y-15.32%
P/S-EPS next 5Y-2.80%
P/B1.99EPS Q/Q-4.24%
Dividend-Sales Q/Q-
Insider Own39.48%Inst Own72.58%
Insider Trans-0.15%Inst Trans1.66%
Short Float31.48%EarningsFeb 18/a
Analyst Recom1.08Target Price19.08
Avg Volume969.27K52W Range6.33 - 15.35
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kunkel Lori AnneDirectorMar 03 '25Option Exercise4.8548,166233,51268,666Mar 04 05:27 PM
Piscitelli DominicChief Financial OfficerDec 15 '24Option Exercise0.0024,0420115,615Dec 17 05:23 PM
Piscitelli DominicChief Financial OfficerDec 16 '24Sale8.288,85173,298106,764Dec 17 05:23 PM
Multani Pratik SChief Medical OfficerDec 15 '24Option Exercise0.0024,042055,615Dec 17 05:22 PM
Multani Pratik SChief Medical OfficerDec 16 '24Sale8.288,85073,29346,765Dec 17 05:22 PM
TKC - Turkcell Iletisim Hizmetleri A.S. ADR - Stock Price Chart
TickerTKC [NYSE]
CompanyTurkcell Iletisim Hizmetleri A.S. ADR
CountryTurkey
IndustryTelecom Services
Market Cap5.07BEPS (ttm)0.49
P/E11.98EPS this Y94.91%
Forward P/E4.74EPS next Y61.21%
PEG-EPS past 5Y0.57%
P/S1.06EPS next 5Y-
P/B0.96EPS Q/Q123.58%
Dividend5.82%Sales Q/Q1.90%
Insider Own0.00%Inst Own3.60%
Insider Trans-Inst Trans0.85%
Short Float0.08%EarningsFeb 27/a
Analyst Recom1.20Target Price9.71
Avg Volume492.06K52W Range5.05 - 8.47
TURKCELL Iletisim Hizmetleri AS engages in the provision of communication and technology services. It operates through the following segments: Turkcell Turkey, Turkcell International, Techfin and All Other. The Turkcell Turkey segment includes the operations of information and entertainment services in Turkey and Azerbaijan, and of non-group call center. The Turkcell International segment includes telecommunications operations in several emerging market geographies. The Techfin segment includes the operations of Turkcell Finansman, Turkcell Odeme, Paycell and Turkcell Sigorta. The All Other segment mainly comprises the information and entertainment services in Turkey, non-group call center operations of Turkcell Global Bilgi, Turkcell Enerji, Boyut Enerji and Turkcell Satis's other operations. The company was founded by Mehmet Ermin Karamehmet and Huseyin Murat Vargi on October 5, 1993, and is headquartered in Maltepe, Turkey.
TPL - Texas Pacific Land Corporation - Stock Price Chart
TickerTPL [NYSE, S&P 500]
CompanyTexas Pacific Land Corporation
CountryUSA
IndustryOil & Gas E&P
Market Cap28.56BEPS (ttm)19.72
P/E63.02EPS this Y12.10%
Forward P/E-EPS next Y-
PEG-EPS past 5Y7.60%
P/S40.47EPS next 5Y-
P/B25.21EPS Q/Q4.80%
Dividend0.44%Sales Q/Q11.50%
Insider Own0.20%Inst Own70.80%
Insider Trans-3.52%Inst Trans4.96%
Short Float6.69%EarningsFeb 19/a
Analyst Recom-Target Price1180.00
Avg Volume126.59K52W Range548.14 - 1769.14
Texas Pacific Land Corporation engages in the land and resource management, and water services and operations businesses. The Land and Resource Management segment manages surface acres of land, and oil and gas royalty interest in Permian Basin. This segment also engages in easements, such as transporting oil, gas and related hydrocarbons, power line and utility, and subsurface wellbore easements. In addition, this segment leases its land for processing, storage, and compression facilities and roads; and is involved in sale of materials, such as caliche, sand, and other material, as well as sells land. The Water Services and Operations segment provides full-service water offerings, including water sourcing, produced-water treatment, infrastructure development, and disposal solutions to operators in the Permian Basin. This segment also holds produced water royalties. The company owns a 1/128th nonparticipating perpetual oil and gas royalty interest (NPRI) under approximately 85,000 acres of land; a 1/16th NPRI under approximately 371,000 acres of land; and approximately 16,000 additional net royalty acres, total of approximately 207,000 NRA located in the Permian Basin. Texas Pacific Land Corporation was founded in 1888 and is headquartered in Dallas, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STAHL MURRAYDirectorMar 20 '25Buy1370.6679,595635,193Mar 21 12:10 PM
STAHL MURRAYDirectorMar 20 '25Buy1370.0034,1108,037Mar 21 12:10 PM
STAHL MURRAYDirectorMar 19 '25Buy1353.3879,474635,192Mar 20 12:57 PM
STAHL MURRAYDirectorMar 19 '25Buy1350.0034,0508,034Mar 20 12:57 PM
STAHL MURRAYDirectorMar 18 '25Buy1343.0479,401635,191Mar 19 11:22 AM
TANH - Tantech Holdings Ltd - Stock Price Chart
TickerTANH [NASD]
CompanyTantech Holdings Ltd
CountryChina
IndustryHousehold & Personal Products
Market Cap2.76MEPS (ttm)1.16
P/E2.00EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-34.32%
P/S0.06EPS next 5Y-
P/B0.15EPS Q/Q-81.21%
Dividend-Sales Q/Q9.04%
Insider Own2.86%Inst Own0.68%
Insider Trans0.00%Inst Trans-35.50%
Short Float12.45%Earnings-
Analyst Recom-Target Price-
Avg Volume219.25K52W Range2.39 - 63.60
Tantech Holdings Ltd. engages in the development and manufacture of bamboo-based charcoal products. It operates through the Consumer Product and Electric Vehicle segments. The Consumer Product segment manufactures, sell and trade Charcoal Doctor branded products and BBQ charcoal in China well as biodegradable packaging business. The Electric Vehicle segment offers solar cells, lithium-ion batteries, auto parts, and electric control systems. The company was founded by Zheng Yu Wang on November 19, 2010 and is headquartered in Lishui, China.
DWTX - Dogwood Therapeutics Inc - Stock Price Chart
TickerDWTX [NASD]
CompanyDogwood Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap11.83MEPS (ttm)-6.31
P/E-EPS this Y13.86%
Forward P/E-EPS next Y-70.81%
PEG-EPS past 5Y-2.02%
P/S-EPS next 5Y5.11%
P/B7.24EPS Q/Q-27.03%
Dividend-Sales Q/Q-
Insider Own21.48%Inst Own1.61%
Insider Trans0.00%Inst Trans-8.31%
Short Float1.76%EarningsNov 07/b
Analyst Recom1.00Target Price30.00
Avg Volume3.72M52W Range1.62 - 29.28
Mar-18-25 08:45AM Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron in Patients with Chemotherapy-Induced Neuropathic Pain (GlobeNewswire) -6.90%
Mar-14-25 12:15PM Biotech Alert: Searches spiking for these stocks today (TipRanks) -20.83%
Mar-13-25 09:00AM Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -27.76%
Mar-12-25 08:30AM Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward (GlobeNewswire)
Jan-21-25 09:15AM Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025 (GlobeNewswire) +68.45%
Nov-18-24 08:45AM Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study (GlobeNewswire) -37.71%
Nov-08-24 02:35AM Q3 2024 Dogwood Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
02:15AM Dogwood Therapeutics Inc (DWTX) Q3 2024 Earnings Call Highlights: Strategic Financing and ... (GuruFocus.com)
Nov-07-24 07:05AM Dogwood Therapeutics Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-31-24 09:15AM Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024 (GlobeNewswire)
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
1234567891018